| Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer HM Kocher, B Basu, FEM Froeling, D Sarker, S Slater, D Carlin, ... Nature communications 11 (1), 4841, 2020 | 151 | 2020 |
| Quantitative Brain MRI in Congenital Adrenal Hyperplasia: In Vivo Assessment of the Cognitive and Structural Impact of Steroid Hormones EA Webb, L Elliott, D Carlin, M Wilson, K Hall, J Netherton, J Reed, ... The Journal of Clinical Endocrinology & Metabolism 103 (4), 1330-1341, 2018 | 43 | 2018 |
| Probing structure of normal and malignant prostate tissue before and after radiation therapy with luminal water fraction and diffusion‐weighted MRI D Carlin, MR Orton, D Collins, NM deSouza Journal of Magnetic Resonance Imaging 50 (2), 619-627, 2019 | 8 | 2019 |
| Variation of T2 relaxation times in pediatric brain tumors and their effect on metabolite quantification D Carlin, B Babourina‐Brooks, NP Davies, M Wilson, AC Peet Journal of Magnetic Resonance Imaging 49 (1), 195-203, 2019 | 6 | 2019 |
| Evaluation of diffusion-weighted MRI and (18F) fluorothymidine-PET biomarkers for early response assessment in patients with operable non-small cell lung cancer treated with … D Carlin, A Weller, G Kramer, Y Liu, JC Waterton, A Chiti, M Sollini, ... BJR| Open 1 (1), 20190029, 2019 | 4 | 2019 |
| Short-acquisition-time JPRESS and its application to paediatric brain tumours D Carlin, B Babourina-Brooks, TN Arvanitis, M Wilson, AC Peet Magnetic Resonance Materials in Physics, Biology and Medicine 32, 247-258, 2019 | 4 | 2019 |
| STARPAC clinical trial HM Kocher, B Basu, FE Froeling, D Sarker, S Slater, D Carlin, ... Pancreatology, 2020 | 2 | 2020 |
| STAR-PAC: Phase I clinical trial repurposing all trans retinoic acid (ATRA) as stromal targeting agent in a novel drug combination for pancreatic cancer HM Kocher, B Basu, FEM Froeling, D Sarker, S Slater, D Carlin, ... Annals of Oncology 30, v267, 2019 | 2 | 2019 |
| A comparison of biexponetial fitting and spectral modelling methods for T2 mapping of prostate cancer D Carlin, MR Orton, VA Morgan, DJ Collins, NM DeSouza Proc 26th Annual Meeting ISMRM, Paris, 2018 | 1 | 2018 |
| An investigation into the importance of T2 relaxation and echo time choice for accurate metabolite biomarker quantification DA Carlin University of Birmingham, 2017 | | 2017 |
| Functionally significant reductions in white matter in patients with congenital adrenal hyperplasia E Webb, L Elliott, D Carlin, M Wilson, K Hall, T Barrett, V Salwani, W Arlt, ... Endocrine Abstracts 45, 2016 | | 2016 |
| Novel brain biomarkers of cognitive abnormalities identified in patients with congenital adrenal hyperplasia EA Webb, L Elliott, D Carlin, K Hall, T Barrett, V Salwani, W Arlt, N Krone, ... Endocrine Abstracts 44, 2016 | | 2016 |
| Identification of Novel Central Nervous System Imaging Biomarkers Associated with Cognitive Abnormalities in Patients with Congenital Adrenal Hyperplasia E Webb, L Elliott, D Carlin, M Wilson, K Hall, T Barrett, V Salwani, W Arlt, ... Deakin University, 2016 | | 2016 |
| T2 Measurements of Childhood Brain Tumours and Metabolite Concentration Correction D Carlin, B Babourina-Brooks, M Wilson, AC Peet Proc. Intl. Soc. Mag. Reson. Med 23, 2015, 2014 | | 2014 |
| ADVANCE ARTICLE EA Webb, L Elliott, D Carlin, M Wilson, K Hall, J Netherton, J Reed, ... | | |
| Characterising prostate tumour growth patterns in men on active surveillance: linking ADC features to growth kinetics D Carlin, VA Morgan, C Parker, NM deSouza | | |
| Early biomarkers of response to neoadjuvant chemotherapy in lung cancer: preliminary data from a multicenter international study D Carlin, A Weller, J Kuijer, GM Kramer, A Chiti, MER O'Brien, S Popat, ... | | |
